Insulin Discontinuation and Other Measures of GLP-1 RA Efficacy

Slideshow

What is the impact on insulin dose, A1c, body weight of adding GLP-1 RA to a MDI insulin regimen? Three studies from ADA 2018 illuminate.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose / image credit: ©New Africa/AdobeStock

Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose

Sydney Jennings
June 18th 2025
Article

Your daily dose of the clinical news you may have missed.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose / image credit: ©New Africa/AdobeStock

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose

Sydney Jennings
June 13th 2025
Article

Your daily dose of the clinical news you may have missed.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating and Reversing Type 2 Diabetes and Prediabetes / image credit ©American College of Lifestyle Medicine

First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating, Reversing Type 2 Diabetes and Prediabetes

Grace Halsey
June 11th 2025
Article

Novel guidelines include specific strategies that support the prescription, implementation, and monitoring of lifestyle changes to reach glycemic control and, possibly, disease remission.

New-Onset T2D Tied to Higher Risk of Obesity-Related Cancer: Daily Dose / image credit: ©New Africa/AdobeStock

New-Onset T2D Tied to Higher Risk of Obesity-Related Cancer: Daily Dose

Sydney Jennings
June 3rd 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.